Status:
COMPLETED
Online Mindfulness-based Cognitive Therapy for Parents of Children With Food Allergies
Lead Sponsor:
Canterbury Christ Church University
Collaborating Sponsors:
University of Surrey
Conditions:
The Quality of Life of Parents of Children With Food Allergy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to conduct an initial evaluation of adapted, live online, mindfulness-based cognitive therapy for parents and carers of children with food allergies (MBCT-PCCFA).
Detailed Description
This study is a pilot randomised controlled trial (RCT) comparing adapted, live online, mindfulness-based cognitive therapy for parents and carers of children with food allergies (MBCT-PCCFA) with a t...
Eligibility Criteria
Inclusion
- Parents or caregivers who identify as having a child under the age of 18 with a food allergy
- The allergy has been diagnosed by a qualified physician (e.g. GP or allergy specialist)
- Mean score of \>=2 on the FAQL-PB, indicating they are at least 'somewhat limited/troubled' by their child's allergy (Cohen et al., 2004).
- Resident in the United Kingdom
- Have access to email, a PC/laptop/tablet with a webcam and microphone and internet access to allow videoconferencing
Exclusion
- They had consulted on the design and content of the intervention or study
- They have already participated in a substantial mindfulness-based course
- They are currently engaged or are planning to engage with another psychological intervention during the course of the study
- They currently engage in regular mindfulness-based practice
- They do not have the practical means and time available to be able to attend the intervention during the dates outlined on the information sheet and commit to at-home practice
- They have scores \>19 on PHQ-8 (indicating 'severe' depressive symptom severity; Kroenke et al., 2009) or \>15 on GAD (indicating 'severe' level of anxiety; Spitzer et al., 2006)
- They have a problem with alcohol or recreational drug misuse
- They have experienced thoughts about harming themselves or others in the last 12 months
- They have been given a diagnosis of psychosis
- They are currently experiencing high levels of distress and/or currently feeling particularly fragile
- They have experienced a bereavement of someone close to them in the last year or are continuing to experience continuing grief in relation to losing someone further back in time
- They have had traumatic experiences that they continue to be troubled by (including, but not limited to, receiving diagnosis of post-traumatic stress disorder)
- They experience significant difficulty being in a group with other people.
- NB: for further details re the FAQL-PB and PHQ-8, please see the outcome measures section.
Key Trial Info
Start Date :
March 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2022
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04738890
Start Date
March 2 2021
End Date
February 2 2022
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salomons Institute for Applied Psychology
Royal Tunbridge Wells, Kent, United Kingdom, TN1 2YG